ArticleThe Lancet regional health. Europe2025

Type 2 diabetes remission after initiation of GLP-1 receptor agonists: frequency, characteristics, and outcomes using multiple definitions in an observational study.

Gian Paolo Fadini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.